Effects on Pharmaceutical Industries by Post Patent Amendment Act, 2005
Pharmaceutical industries are one of the major industries in India.
They were popularly known for their ‘Reverse engineering process’ that is to
say they used to decipher the product by different process and produce the
generic version of the previous patented product. Before, Patent Amendment Act,
2005 as there was no product patent in India so, these pharmaceutical
industries were able to produce the generic versions of the product. But after
this 2005 amendment, product patent was introduced in the Act and with the
advent of this product patent; it became difficult for them to produce the
generic versions. As a result they were left with only two options, first either
they can opt for voluntary license or they can opt for compulsory license. But
generally the MNC’s resists themselves in giving voluntary license to generic
companies as a result there was a huge problem being faced by these generic
companies. The concept of compulsory license existed in the patent act from
very beginning but none of the companies were able to acquire the same.
Compulsory license has been dealt under section 84 of the Patent Act,
1970. The requirements for grant of the same are: That after expiration of 3
years from grant of Patents can apply for compulsory license on following
grounds-
1. That the reasonable requirements of the public are not being
satisfied
2. That the invention is not available to the public at large
3 that it is not worked in the territory of India
After the latest amendment made to Patent Act in 2005, the first case
of grant of compulsory license was Natco i.e. Natco v Bayer. As it was a case
related to some life saving drugs which was available in the market at
exorbitantly high prices therefore, Natco one of the generic pharmaceutical
company applied for compulsory license and it has been granted the same by the
court.
Therefore,
in my opinion in case of life saving drugs/medicines, compulsory licenses should
be given to these generic companies so that the poor masses can easily purchase
the same as one of the object of Patent law is also public welfare i.e in the
interest of general public specially for the weaker sections of the society who
are unable to buy these medicines at high price, it is always advisable to
acquire compulsory license from the controller of Patents office. Thus, the
legal formalities or the complex procedure for grant of compulsory license
should be simplified in order to make these medicines accessible to general
public at large.
Comments
Post a Comment